Add BrightSurf on Google Email

New platform combines precision gene targeting with brain-wide delivery

A new study describes a gene therapy strategy that uses the brain's glymphatic transport system to distribute engineered viral vectors throughout the brain. This approach enables preferential targeting of human glial cells while minimizing exposure to other cell types and organs, addressing two major challenges in neurological medicine.

SourceUniversity of Rochester Medical Center·JournalNature Biotechnology·DateJul 8, 2026

Human-safe drug repairs DNA in a mouse model of Alzheimer's

Scientists at King's College London have developed a human-safe drug that repairs DNA breaks and reduces inflammation in a mouse model of Alzheimer's disease. This approach targets multiple features of the disease simultaneously, providing a broader therapeutic strategy than previous approaches focused on individual disease hallmarks.

SourceKing's College London·JournalFEBS Open Bio·TypeExperimental study·DateJul 8, 2026

Emerging evidence links tire pollution to Alzheimer’s risk

A new study links tire pollution to Alzheimer's disease through the exposure to 6PPD-quinone, a chemical formed from shaved-off tire particles. The researchers used computational methods to identify key genes that predict Alzheimer's disease and found strong binding of 6PPD-quinone to these genes.

SourceDe Gruyter Brill·JournalOpen Medicine·TypeComputational simulation/modeling·DateJul 6, 2026

A theoretical framework and hypothesis linking rubidium ion metabolic dysregulation to Parkinson’s disease pathogenesis

Researchers propose a theoretical framework linking rubidium ion metabolic dysregulation to Parkinson's disease, highlighting the role of ionic homeostasis imbalance in neurodegeneration. Rubidium may serve as a potential biomarker and therapeutic target for early intervention.

SourceChina Association of Chinese Medicine, eTM·JournalWorld Journal of Integrated Traditional and Western Medicine·TypeData/statistical analysis·DateJul 3, 2026

How a brain messenger protein drives progression of Alzheimer’s disease

Researchers discovered that a brain protein called Arc helps spread toxic Tau from sick brain cells to healthy ones in mice. This finding suggests that targeting the spread of Tau could be a powerful tool to stop Alzheimer's disease progression. The study also highlights the potential protective role of Arc in early stages of the disease.

SourceUniversity of Utah Health·JournalCell·TypeExperimental study·DateJun 29, 2026

Mount Sinai researchers identify RNA biomarkers that could offer a simple blood test for earlier Alzheimer’s diagnosis

Researchers discovered blood RNA biomarkers that could support earlier diagnosis of Alzheimer's disease, potentially reducing the need for invasive tests. They identified brain-specific markers in circulating blood nanoparticles, which may offer a minimally invasive approach for diagnosing the progressive neurodegenerative disease.

University of Michigan implants first-in-human Paradromics wireless brain-computer interface, designed to restore communication

Researchers at University of Michigan Health have implanted the first wireless brain-computer interface (BCI) to restore communication in a patient with motor neuron disease. The study, called Connect-One Early Feasibility Study, aims to assess the device's long-term safety and effectiveness in synthesizing text and speech.

SourceMichigan Medicine - University of Michigan·TypeExperimental study·DateJun 17, 2026

University of Michigan implants first-in-human Paradromics wireless brain-computer interface, designed to restore communication

The University of Michigan has successfully implanted the first-in-human Paradromics wireless brain-computer interface, designed to restore communication for patients with difficulty speaking. The clinical trial will focus on the device's long-term safety and assess its ability to restore communication through synthesized text and speech.

SourceMichigan Medicine - University of Michigan·TypeExperimental study·DateJun 17, 2026

Retinal photographs can help predict Alzheimer’s disease risk factors

A new study revealed that retinal photographs can accurately predict many common risk factors associated with developing Alzheimer's disease. The AI model identified regions of the retina linked to Alzheimer's risk factors, such as arteries and optical nerve, and predicted lifestyle factors like smoking and alcohol use.

SourceUniversity of Florida·JournalJournal of Alzheimer’s Disease·TypeComputational simulation/modeling·DateJun 16, 2026

LiON: A fluorescent molecule for tracking iron and oxygen levels in individual cells

Researchers developed LiON, a fluorescent reporter that visualizes biologically active iron and oxygen inside living cells. The tool revealed striking differences in iron and oxygen distribution across organs and cells, offering new opportunities to study diseases like cancer, liver disorders, and neurodegenerative conditions.

SourceInstitute of Science Tokyo·JournalCell Reports Methods·TypeExperimental study·DateJun 16, 2026

A nasal spray reaches a woman's brain differently depending on the week, and it may explain why a promising brain drug looked like a failure

A new study found that intranasal davunetide reaches the brain in higher amounts in female mice when estrogen peaks, with similar results seen in healthy adults. The findings suggest earlier trials mixing males and females may have obscured the true effects of the drug.

SourceGenomic Press·JournalGenomic Psychiatry·TypeExperimental study·DateJun 16, 2026

Can obesity make the brain age faster?

A new study investigates whether obesity contributes to faster brain aging and earlier memory decline. Researchers found that high K63 polyubiquitination levels in young obese rats matched those seen in older brains, suggesting a connection between obesity-induced and age-related memory loss.

Virtual-reality path integration for predicting risk of neurodegenerative diseases

Researchers found that impaired virtual reality path integration was closely tied to brain structure and biomarkers associated with neurodegeneration. This suggests that VR-based navigation errors may reveal hidden changes in the brain long before symptoms arise, making it a promising behavioral marker for preclinical Alzheimer's disease.

SourceFujita Health University·JournalAlzheimer s Research & Therapy·TypeObservational study·DateMay 27, 2026

Alzheimer’s drug analysis may lead to misinterpretations of drug's effects, study finds

A new statistical approach used in Alzheimer's disease trials may exaggerate the link between amyloid reduction and cognitive benefits of new drugs. Researchers found that combining large groups of patients can hide variability and make it appear as if reducing amyloid is more predictive of cognitive benefit than it actually is.

SourceBrown University·JournalJAMA Neurology·TypeData/statistical analysis·DateMay 18, 2026

Inexpensive material compresses light, paving the way for photonic microcircuits in the terahertz range

Researchers developed a new photonic material using lead iodide, enabling high-speed data transmission in the terahertz frequency range. The material confines light within submicrometer regions, paving the way for integrated photonic circuits that could replace or complement electronic circuits.